Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Profit Margin

Share:
Related UTHR
The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut
Earnings Scheduled For October 31, 2018
Related RDY
The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO
40 Biggest Movers From Yesterday
Dr. Reddy's launches Omeprazole, 20mg in U.S. (Seeking Alpha)

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of profit margin.

The trailing-twelve-month profit margin at United Therapeutics (NASDAQ: UTHR) is 30.05%. United Therapeutics' revenue for the same period is $1.01 billion.

The trailing-twelve-month profit margin at Warner Chilcott plc (NASDAQ: WCRX) is 18.89%. Warner Chilcott's operating margin for the same period is 32.10%.

The trailing-twelve-month profit margin at Dr. Reddy's Laboratories (NYSE: RDY) is 14.36%. Dr. Reddy's ROE for the same period is 25.28%.

The trailing-twelve-month profit margin at Cubist Pharmaceuticals (NASDAQ: CBST) is 10.23%. Cubist Pharmaceuticals' PEG ratio is 2.13.

Posted-In: Drug Manufacturers-Other Industry Highest Profit Margin mid-cap stocksTrading Ideas

 

Related Articles (CBST + RDY)

View Comments and Join the Discussion!

Top 4 Mid-Cap Stocks In The Residential Construction Industry With The Highest Cash

Top 4 Large-Cap Stocks In The Auto Parts Industry With The Lowest PEG Ratio